Differences
This shows you the differences between two versions of the page.
Next revision | Previous revisionBoth sides next revision | ||
blog:bpaddock:mri_contrast_gadolinium_toxicity [2014/07/06 23:50] bpaddock MRI Contrast Gadolinium Toxicity | blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:53] bpaddock | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== MRI Contrast Gadolinium Toxicity ====== | ====== MRI Contrast Gadolinium Toxicity ====== | ||
+ | European regulators want some forms of Gadolinium contrast agents pulled from the market. | ||
+ | |||
+ | PRAC concludes assessment of gadolinium agents used in | ||
+ | body scans and recommends regulatory actions, including | ||
+ | suspension for some marketing authorisations. | ||
+ | |||
+ | The linear gadolinium products gadobenic acid, gadopentetic acid, gadodiamide, | ||
+ | |||
+ | http:// | ||
+ | |||
+ | http:// | ||
{{page>: | {{page>: |